blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2121751

EP2121751 - MONOCLONAL ANTIBODIES AGAINST ANGPTL3 [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.12.2017
Database last updated on 18.01.2025
FormerThe patent has been granted
Status updated on  23.12.2016
FormerGrant of patent is intended
Status updated on  14.12.2016
Most recent event   Tooltip11.10.2019Lapse of the patent in a contracting state
New state(s): CY		published on 13.11.2019  [2019/46]
Applicant(s)For all designated states
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160 / US
[2009/48]
Inventor(s)01 / LEE, E-chiang
3 White Wing Ct.
The Woodlands, Texas 77382 / US
02 / LANDES, Gregory
35 Silvermont Dr.
The Woodlands, Texas 77382 / US
03 / HONG, Seokjoo
11 Heron Hollow Ct.
The Woodlands, Texas 77382 / US
04 / DESAI, Urvi
14 Columnberry Ct.
The Woodlands, Texas 77384 / US
05 / POWELL, David
5327 Stillbrooke Dr.
Houston, Texas 77096 / US
06 / FENG, Xiao
162 E. Concord Valley Circle
The Woodlands, TX 77382 / US
 [2009/48]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2017/04]
Former [2009/48]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Leopoldstrasse 4
80802 München / DE
Application number, filing date07862629.806.12.2007
[2009/48]
WO2007US25080
Priority number, dateUS20060873834P08.12.2006         Original published format: US 873834 P
[2009/48]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008073300
Date:19.06.2008
Language:EN
[2008/25]
Type: A2 Application without search report 
No.:EP2121751
Date:25.11.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 19.06.2008 takes the place of the publication of the European patent application.
[2009/48]
Type: B1 Patent specification 
No.:EP2121751
Date:25.01.2017
Language:EN
[2017/04]
Search report(s)International search report - published on:US23.12.2009
(Supplementary) European search report - dispatched on:EP08.12.2011
ClassificationIPC:A61K39/395, C07K16/22, A61P3/06
[2011/52]
CPC:
C07K16/22 (EP,US); A61K39/395 (KR); A61P3/00 (EP);
A61P3/04 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P9/00 (EP); A61P9/10 (EP); C07K16/18 (KR);
A61K2039/505 (EP,US); C07K2317/33 (EP,US); C07K2317/34 (EP,US);
C07K2317/76 (EP,US); C07K2317/92 (EP,US) (-)
Former IPC [2009/48]C07K16/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/04]
Former [2009/48]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL08.07.2009
BA08.07.2009
HR08.07.2009
MK08.07.2009
RS08.07.2009
TitleGerman:MONOKLONALE ANTIKÖRPER GEGEN ANGPTL3[2009/48]
English:MONOCLONAL ANTIBODIES AGAINST ANGPTL3[2009/48]
French:ANTICORPS MONOCLONAUX DIRIGÉS CONTRE ANGPTL3[2009/48]
Entry into regional phase08.07.2009National basic fee paid 
08.07.2009Search fee paid 
08.07.2009Designation fee(s) paid 
08.07.2009Examination fee paid 
Examination procedure08.07.2009Examination requested  [2009/48]
22.06.2012Amendment by applicant (claims and/or description)
24.09.2012Despatch of a communication from the examining division (Time limit: M06)
22.03.2013Reply to a communication from the examining division
24.01.2014Despatch of a communication from the examining division (Time limit: M04)
02.06.2014Reply to a communication from the examining division
19.06.2015Despatch of a communication from the examining division (Time limit: M04)
19.09.2015Reply to a communication from the examining division
04.08.2016Communication of intention to grant the patent
08.12.2016Fee for grant paid
08.12.2016Fee for publishing/printing paid
08.12.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.09.2012
Opposition(s)26.10.2017No opposition filed within time limit [2018/01]
Fees paidRenewal fee
11.12.2009Renewal fee patent year 03
15.12.2010Renewal fee patent year 04
12.12.2011Renewal fee patent year 05
11.12.2012Renewal fee patent year 06
12.12.2013Renewal fee patent year 07
11.12.2014Renewal fee patent year 08
10.12.2015Renewal fee patent year 09
13.12.2016Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY25.01.2017
EE25.01.2017
FI25.01.2017
LT25.01.2017
LV25.01.2017
MC25.01.2017
RO25.01.2017
SI25.01.2017
SK25.01.2017
IS25.05.2017
[2019/46]
Former [2019/30]EE25.01.2017
FI25.01.2017
LT25.01.2017
LV25.01.2017
MC25.01.2017
RO25.01.2017
SI25.01.2017
SK25.01.2017
IS25.05.2017
Former [2018/14]EE25.01.2017
FI25.01.2017
LT25.01.2017
LV25.01.2017
RO25.01.2017
SI25.01.2017
SK25.01.2017
IS25.05.2017
Former [2017/49]EE25.01.2017
FI25.01.2017
LT25.01.2017
LV25.01.2017
RO25.01.2017
SK25.01.2017
IS25.05.2017
Former [2017/41]FI25.01.2017
LT25.01.2017
LV25.01.2017
IS25.05.2017
Documents cited:Search[XI]WO03044172  (GENENTECH INC [US]) [X] 1-3,6-8,24-26 * examples 1-3 * * page 2, paragraph 10 * * page 3, paragraphs 12,13 * [I] 4,5,9-23;
 [I]  - OIKE ET AL, "Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy", TRENDS IN MOLECULAR MEDICINE, ELSEVIER CURRENT TRENDS, GB, (20050101), vol. 11, no. 10, doi:10.1016/J.MOLMED.2005.08.002, ISSN 1471-4914, pages 473 - 479, XP005104728 [I] 1-26 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.molmed.2005.08.002
 [I]  - KÖSTER ANJA ET AL, "Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism", ENDOCRINOLOGY, (20051101), vol. 146, no. 11, pages 4943 - 4950, XP002416691 [I] 1-26 * the whole document *

DOI:   http://dx.doi.org/10.1210/EN.2005-0476
 [A]  - GE H ET AL, "DIFFERENTIAL REGULATION AND PROPERTIES OF ANGIOPOIETIN-LIKE PROTEINS 3 AND 4", JOURNAL OF LIPID RESEARCH, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US, (20050701), vol. 46, no. 7, doi:10.1194/JLR.M500005-JLR200, ISSN 0022-2275, pages 1484 - 1490, XP008051641 [A] 1-26 * the whole document *

DOI:   http://dx.doi.org/10.1194/jlr.M500005-JLR200
International search[A]WO9967382  (COMPUGEN LTD [IL], et al);
 [Y]US6074873  (FONG SHERMAN [US], et al);
 [Y]WO02101039  (SANKYO CO [JP], et al);
 [X]US2003100051  (RUBEN STEVEN M [US], et al);
 [X]US2003215451  (FERRARA NAPOLEONE [US], et al);
by applicantUS3773919
 US4179337
 EP0036676
 EP0058481
 US4399216
 EP0088046
 EP0133988
 EP0143949
 EP0154316
 WO8801649
 US4740461
 US4816567
 US4912040
 US4946778
 US4959455
 EP0401384
 WO9216221
 US5260203
 WO9513312
 WO9534326
 WO9611953
 US5530101
 WO9619459
 US5585089
 US5693762
 US5693761
 WO9824893
 US5766886
 US5869619
 US5877397
 WO9925044
 US5912000
 US5965144
 US5980912
 US6075181
 US6114598
 US6180370
 WO03044172
 WO2006074228
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.